It was found that serum from individuals with gastric cancer, pancreatic cancer, lung cancer, breast cancer, and medullary thyroid carcinoma had higher levels of CEA than healthy individuals. The gene discussed is CEACAM5; the disease is familial pancreatic carcinoma.